making democrats rich: Vaccine maker Pfizer has reported record revenues for 2022, with its COVID-19 products accounting for a large chunk of the sales even as the company is facing backlash for claiming to “mutate” viruses, and a growing number of doctors are turning away from boosters.

by

Full-year revenues for 2022 came in at $100.3 billion, which is an “all-time high” for the multinational corporation, according to the earnings release by Pfizer on Jan. 31.